Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
American Journal of Hematology
|
April 26, 2005
Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy
Jay Rajda, Pradyumna D Phatak
Hematology (Amsterdam, Netherlands)
|
December 12, 2003
Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients
Pradyumna D Phatak, James C Barton
Annals of Hematology
|
April 18, 2024
Diagnosing aceruloplasminemia: navigating through red herrings
Zeni Kharel, Himal Kharel, Pradyumna D Phatak
Current Medical Research and Opinion
|
February 13, 2009
Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders
Thomas E Delea, May Hagiwara, Pradyumna D Phatak
Annals of Internal Medicine
|
August 20, 2008
Hereditary hemochromatosis: time for targeted screening
Pradyumna D Phatak, Herbert L Bonkovsky, Kris V Kowdley
The American Journal of the Medical Sciences
|
February 15, 2021
Bilateral Perinephric Stranding and Diffuse Bone Lesions
Mohammad Ammad Ud Din, Syed Ather Hussain, Pradyumna D Phatak
Blood
|
July 11, 2009
Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation
Ronald L Sham, Pradyumna D Phatak, Elizabeta Nemeth, et al.
Blood Cells, Molecules & Diseases
|
February 25, 2005
Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features
Ronald L Sham, Pradyumna D Phatak, Carol West, et al.
The Journal of Rheumatology
|
January 1, 2003
Association of heterozygous hemochromatosis C282Y gene mutation with hand osteoarthritis
James M Ross, Roman M Kowalchuk, Jennifer Shaulinsky, et al.
American Journal of Hematology
|
October 11, 2007
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States
Thomas E Delea, May Hagiwara, Simu K Thomas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
American Journal of Hematology
|
April 26, 2005
Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy
Jay Rajda, Pradyumna D Phatak
Hematology (Amsterdam, Netherlands)
|
December 12, 2003
Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients
Pradyumna D Phatak, James C Barton
Annals of Hematology
|
April 18, 2024
Diagnosing aceruloplasminemia: navigating through red herrings
Zeni Kharel, Himal Kharel, Pradyumna D Phatak
Current Medical Research and Opinion
|
February 13, 2009
Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders
Thomas E Delea, May Hagiwara, Pradyumna D Phatak
Annals of Internal Medicine
|
August 20, 2008
Hereditary hemochromatosis: time for targeted screening
Pradyumna D Phatak, Herbert L Bonkovsky, Kris V Kowdley
The American Journal of the Medical Sciences
|
February 15, 2021
Bilateral Perinephric Stranding and Diffuse Bone Lesions
Mohammad Ammad Ud Din, Syed Ather Hussain, Pradyumna D Phatak
Blood
|
July 11, 2009
Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation
Ronald L Sham, Pradyumna D Phatak, Elizabeta Nemeth, et al.
Blood Cells, Molecules & Diseases
|
February 25, 2005
Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features
Ronald L Sham, Pradyumna D Phatak, Carol West, et al.
The Journal of Rheumatology
|
January 1, 2003
Association of heterozygous hemochromatosis C282Y gene mutation with hand osteoarthritis
James M Ross, Roman M Kowalchuk, Jennifer Shaulinsky, et al.
American Journal of Hematology
|
October 11, 2007
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States
Thomas E Delea, May Hagiwara, Simu K Thomas, et al.
Page
of 3